Primary Prevention Of Cervical Cancer Research Articles

A Feasibility Study of a Behavioral Intervention to Increase Uptake of Human Papillomavirus (HPV) Vaccination in Envigado, Colombia

PURPOSE The estimated HPV vaccination coverage in Colombia is approximately 39%, falling short of the 90% goal set by the Global Strategy for Cervical Cancer Elimination proposed by the WHO for 2030. The aim of this study was to evaluate the feasibility of a behavioral intervention named Super Protegidas, to increase HPV vaccination of girls aged 9 to 14 years. Following the recommendations of the ORBIT model for behavioral interventions development, the problem was conceptualized, an intervention was designed with stakeholders, and the results of the feasibility phase are presented here. METHODS The protocol, based on the COM-B model, focuses on dyads of girls and caregivers. For the girls, a playful pedagogical workshop was conducted in two schools, addressing primary prevention of cervical cancer through HPV vaccination. For parents, the protocol includes a letter, a series of multimedia messages with text, a video on cervical cancer prevention, and a reminder message the day before vaccination. After conducting this intervention, a feasibility study was carried out through semi-structured telephone interviews with participating caregivers. This aimed to assess acceptability, retention, comprehension, effort required to participate, and suggestions for improvement. RESULTS Fifteen dyads of girls and their caregivers participated, with an 80% sample retention completing both the intervention and the telephonic interview. Of these, 69.2% did not watch the videos, 83.3% read the letter with their daughter, 100% were pleased with the intervention, the clarity of the messages, and the delivery method. Regarding areas for improvement, 41.6% suggested avoiding videos due to the time required to watch them and recommended sending messages in the early hours of the night as this increases the likelihood of reading them. CONCLUSION The intervention was well-received by participants and deemed feasible by researchers. Adjustments are needed to enable participants to access information in a more timely manner.

Human Papillomavirus Vaccine Awareness and Acceptability for Primary Prevention of Cervical Cancer in Pakistan: A Cross-Sectional Study.

Human papillomavirus (HPV) vaccine is the most effective option for primary prevention HPV, a well-known cause of cervical cancer. The objective of the study was to assess awareness of HPV, the acceptability of its vaccine and factors associated with the acceptability among the adult population in Pakistan. A cross-sectional survey was conducted among adult population of Pakistan from January 2022 and March 2022. Due to the ongoing COVID-19 pandemic, instead of face-to-face interviews, a self-administered questionnaire was developed and distributed through Google Forms. The questionnaire was available in both English and Urdu languages to cater to a diverse population. Overall, 313 (65.2 %) study participants had heard about HPV infection, while 297 (61.9%) knew HPV as the cause of genital warts and 256 (53.3 %) knew that HPV can cause any type of cancer, with a higher percentage of awareness among those who were in any health care setting compared to those who were in a non-healthcare setting. Regarding the acceptability to get HPV vaccine, 320 (66.7%) of the study participants were willing to get vaccinated, while only 15(3.1%) of the study population had previously received HPV vaccine. The most important factors associated with HPV vaccine acceptability were younger age of 18-25 years (Prevalence Ratio (PR) =1.60, 95% Confidence Interval (CI) =1.11, 2.32), and 26-35 years (PR= 1.65, 95% CI=1.09, 2.50). HPV vaccine acceptability was also associated with working in a healthcare setting due to better awareness of HPV vaccine (PR= 1.29, 95% CI=1.03, 1.62). It is important to address the knowledge gaps existing in the community about HPV vaccine acceptability and barriers against it for the successful rollout of the HPV vaccination program in Pakistan. Mass awareness campaigns about HPV, HPV vaccine, and cervical cancer are needed to increase the acceptability of HPV vaccine among public at the time of reintroducing HPV vaccine.

PRIMARY PREVENTION OF CERVICAL CANCER WITH VIDEO MEDIA FOR POSYANDU CADRES

Cervical cancer is one of the malignancies of the female reproductive organs with a long pathophysiology. Early detection with Visual Acetate Inspection (VIA) and Pap Smear can prevent poor prognosis. However, the evaluation of the coverage of the achievement of the program is still low. The study aimed to analyze the effectiveness of primary prevention education on cervical cancer using video media to increase the knowledge of posyandu cadres. Type of experimental research categorical paired. The sample was 56 posyandu cadres who were selected by purposive sampling. Knowledge data collection was done with pretest and posttest questionnaires. Data analysis was performed with Wilcoxon (ρ=0.005). The results showed an increase in the median value of knowledge pretest 65.00 to the posttest median of 85.00. Video media effectively increases the knowledge of posyandu cadres about the early detection of cervical cancer (ρ=0.000). Health education with video media proved effective in increasing the knowledge of posyandu cadres about the primary prevention of cervical cancer. It is hoped that this study can contribute to improving the ability of human resources in promotive efforts through interactive media-based health promotion.

Cervical Cancer Prevention in Rural Areas.

Globally, cervical cancer (CC) incidence is higher in rural areas than in urban areas that could be explained by the influence of many factors, including inequity in accessibility of the CC prevention measures. This review aimed to identify and analyze factors associated with a lack of cervical cancer screening and HPV vaccination programs in people living in rural areas and to outline strategies to mitigate these factors. The literature search encompassed two focal domains: cervical cancer screening and HPV vaccination among populations residing in rural areas, covering publications between January 1, 2004 to December 31, 2021 in the PubMed, Google Scholar, Scopus, and Cyberleninka databases, available in both English and Russian languages. A literature review identified 22 sources on cervical cancer screening and HPV vaccination in rural and remote areas. These sources revealed similar obstacles to screening and vaccination in both high and low-income countries, such as low awareness and knowledge about CC, screening, and HPV vaccination among rural residents; limited accessibility due to remoteness and dearth of medical facilities and practitioners, associated with a decrease in recommendations from them, and financial constraints, necessitating out-of-pocket expenses. The reviewed sources analyzed strategies to mitigate the outlined challenges. Possible solutions include the introduction of tailored screening and vaccination campaigns designed for residents of rural and remote locations. New screening and vaccination sites have been proposed to overcome geographic barriers. Integrating HPV testing-based CC screening is suggested to counter the lack of healthcare personnel. HPV vaccination is essential for primary cervical cancer prevention, especially in rural and remote areas, as it requires less medical infrastructure. Certain measures can be proposed to improve the uptake of CC screening and HPV vaccination programs among rural residents, which are needed to address the higher prevalence of CC in rural areas. Further investigation into cervical cancer prevention in rural and remote contexts is necessary to ascertain the optimal strategies that promote health equity.

Efficacy of HPV vaccine in preventing cervical cancer in the Tomsk region

Background. The age-standardized cervical cancer incidence rate in the Tomsk region in 2021 was consistently higher than the average for the Russian Federation (21.2 / 100,000 versus 13.6 / 100,000 women). Primary prevention of cervical cancer is best achieved by human papillomavirus (HPV) vaccination of girls. Aim. To evaluate HPV vaccine efficacy for the prevention of cervical cancer in the Tomsk region within the framework of implementation of two regional programs: “Prevention of gynecological cancer and rehabilitation of women diagnosed with gynecological cancer in 2008–2010” and “Urgent measures to improve cancer care for the population of the Tomsk region in 2011–2013”. Material and methods. We studied the tolerability and efficacy of HPV vaccination for the prevention of HPV-associated cervical cancer in 439 vaccinated girls aged 9–26 years during a follow-up time of 14-years. Results. The assessment of a 14-year follow-up study of the impact of HPV vaccination on HPV-associated cervical lesions has shown that HPV vaccine is safe and 100 % effective. Conclusion. Further prospects for primary prevention of cervical cancer before the introduction of vaccines against HPV infection in the national immunization schedule indicates the feasibility and real clinical effectiveness of the introduction of regional and regional programs with the development of a mathematical model for optimizing financial costs for primary prevention of cervical cancer, taking into account demographic parameters and socio-economic damage from cervical cancer in the study area.

Cervical Cancer Prevention Knowledge (Cckp-64) among Female Students in Novi Sad, Serbia during COVID-19 Pandemic.

Cervical cancer is a significant global health concern affecting young women, with over 500,000 new cases reported annually. This questionnaire-based study aimed to evaluate the knowledge of cervical cancer prevention among female students at the University of Novi Sad during the COVID-19 pandemic using the Cervical Cancer Knowledge Prevention-64 (CCKP-64) tool. The study sample consisted of 402 predominantly 20-22-year-old female students from either social or technical science faculties in urban environments. Results revealed that out of the 402 female students involved in the study, most had a good general knowledge of primary prevention of cervical cancer, with a correct answer rate ranging from 29.9 to 80.6%. On the contrary, only 63.4% of female students have heard about the vaccine against cervical cancer; 52.0% know that the vaccine exists in Serbia; and 31.8% know where to get vaccinated. Only a small proportion of students (9.7%) have encountered cervical cancer among their relatives/friends and think that the disease could affect them in the future (25.4%). Older students (>26 years) generally (p < 0.05) had better knowledge regarding distressing symptoms of cervical cancer, cytological examination and secondary prevention; however, it was also noted that a significant percentage of this age group reported not having received vaccinations (53.0%, p = 0.001). This study underscores the need for increased awareness and education about the HPV vaccine and secondary prevention among young women in Serbia. Future research should investigate knowledge and attitudes toward cervical cancer prevention in diverse populations to develop effective interventions and strategies. These findings have implications for public health policies in Serbia to promote cervical cancer prevention among young women.

Cervical cancer incidence and mortality in the Republic of Bashkortostan: The role of human papillomavirus in the development of cervical cancer

BACKGROUND: Malignant neoplasms (MNs) have been the most urgent problem in medicine worldwide for more than a decade. The steady increase in morbidity and mortality from oncological diseases has led to socio-demographic problems and high economic costs.&#x0D; AIM: This study aimed to assess the incidence and mortality of cervical cancer (CC) in the Republic of Bashkortostan over a 6-year period.&#x0D; MATERIALS AND METHODS: This study was conducted from 2015 to 2020 according to the reporting form Information on malignant neoplasms. The data were evaluated based on the analysis of statistical data on morbidity and mortality from MNs in the Republic of Bashkortostan and the Russian Federation. Cartography was conducted using the R software, ggplot2 package. Statistical analysis was performed using the Statistica 10 program. Standardized indicators were used to analyze morbidity and mortality.&#x0D; RESULTS: In the Russian Federation, 299,967 newly diagnosed MN cases in women were recorded in 2020. The most significant cause of oncological morbidity in women is MNs of the reproductive system (38.8%), where tumors of the genital organs account for 17.6% of all MNs in women. The standardized incidence rate of cervical cancer in 2020 was 13.67 per 100,000 population in the Russian Federation, and 10.9 per 100,000 population in the Republic of Bashkortostan.&#x0D; CONCLUSIONS: The process of CC development is quite long, and it should be diagnosed and treated at the dysplastic stage. The necessity of introducing HPV testing into widespread practice for the rapid screening of CC is obvious. Moreover, the primary prevention of CC by vaccination against the human papillomavirus of high carcinogenic risk is also important.

Информированность населения о первичной профилактике рака шейки матки

A proven effective preventive measure against cervical cancer is a full-fledged HPV vaccination course conducted before the start of the patient’s sexual life. Its cost is essential for the realization of the possibility of using the vaccine on a voluntary basis. However, the most important argument for making a decision about vaccination is the awareness of patients about its expediency, effectiveness and safety. P u r p o s e : to identify the level of awareness of the population about the primary prevention of cervical cancer by vaccination against HPV. M a t e r i a l s a n d m e t h o d s . According to a specially developed questionnaire, an anonymous survey of adolescents and their parents (legal representatives) on the organization of HPV vaccination was conducted. The quota sample for the survey included 723 respondents who applied to women’s consultations and children’s polyclinics in St. Petersburg (a total of 19 medical organizations). R e s u l t s . In fact, only 59,7% of respondents are informed about diseases caused by HPV, and another 5,1% of those who took part in the survey are mistaken about this. Only one in three (36,4%) respondents know about the safety of currently used vaccines, and the majority of respondents – 50,8% noted that they do not know anything about this issue. Among the respondents, 87,8% indicated that given the high importance of vaccination to prevent the development of oncological diseases of the female genital area, HPV vaccinations should be carried out free of charge to citizens within the framework of the National Vaccination Calendar and the calendar of preventive vaccinations for epidemic indications. F i n d i n g s . A sociological study showed an unsatisfactory level of knowledge of the population on the issues of primary prevention of malignant neoplasms of the female genital organs.

Types and importance of human papilloma virus vaccine and methods in promoting it for cervical cancer prevention

Cervical cancer continues to be a significant global challenge as it is the fourth major cause of mortality among women. Cervical cancer is primarily caused by repeated human papilloma virus (HPV) infections. Although the incidence and death of cervical cancer have declined in high-income nations, the disease still places a heavy burden on low- and middle-income countries. HPV-16Cervical cancer continues to be a significant global challenge as it is the fourth major cause of mortality among women. Cervical cancer is primarily caused by repeated human papilloma virus (HPV) infections. Although the incidence and death of cervical cancer have declined in high-income nations, the disease still places a heavy burden on low- and middle-income countries. HPV-16 is responsible for 50% while HPV-18 is responsible for 10% of cervical cancer cases. The introduction of HPV vaccines is limited in developing areas with greater need, despite the fact that they offer a potential alternative for disease control. The purpose of this research is to review the available information about types and importance of HPV vaccine and methods in promoting it for cervical cancer prevention. Three HPV vaccines for prevention of cervical cancer are available including a quadrivalent vaccine that protects against 4 HPV types, and the second is a bivalent vaccine that protects against 2 high-risk oncogenic HPV types and third is a 9-valent vaccine. All three vaccines provide comparable coverage. Preventative vaccinations against the virus, given to women before HPV infection, have proven to be efficient and have the potential to reduce the incidence of cervical cancer. Thus, it is advised to immunize girls aged 9-14 years. The development of the HPV vaccine has made primary cervical cancer prevention possible. Health promotion and education can potentially contribute to increasing the awareness of community regarding cervical cancer prevention and can lead to better utilization of HPV vaccine.is responsible for 50% while HPV-18 is responsible for 10% of cervical cancer cases. The introduction of HPV vaccines is limited in developing areas with greater need, despite the fact that they offer a potential alternative for disease control. The purpose of this research is to review the available information about types and importance of HPV vaccine and methods in promoting it for cervical cancer prevention. Three HPV vaccines for prevention of cervical cancer are available including a quadrivalent vaccine that protects against 4 HPV types, and the second is a bivalent vaccine that protects against 2 high-risk oncogenic HPV types and third is a 9-valent vaccine. All three vaccines provide comparable coverage. Preventative vaccinations against the virus, given to women before HPV infection, have proven to be efficient and have the potential to reduce the incidence of cervical cancer. Thus, it is advised to immunize girls aged 9-14 years. The development of the HPV vaccine has made primary cervical cancer prevention possible. Health promotion and education can potentially contribute to increasing the awareness of community regarding cervical cancer prevention and can lead to better utilization of HPV vaccine.

Human Papillomavirus (Hpv) Vaccination of The Girl Child: An Intervention for Primary Prevention of Cervical Cancer in India

This review gives a comprehensive account of the currently available HPV vaccines including the Nonavalent vaccine which was not covered by some articles. The review includes the current burden of cervical cancer globally and in India. It also outlines the cervical cancer elimination initiative envisaged by the National Health Mission and the World Health Organization. This review aims to highlight the importance of cervical cancer prevention through HPV vaccination and regular screening program. The Human Papillomavirus infection is an established cause of cervical cancer in women. Cervical cancer is the second leading cause of cancer deaths among women in India. India has a young population with more than 436.7 million women aged 15 years and older at risk of developing cervical cancer. There is mounting evidence that cervical cancer is highly preventable. Primary prevention can be done effectively by vaccinating adolescent girls aged 9 to 14 years with the HPV vaccine. Three HPV vaccines, namely the Bivalent, Quadrivalent, and Nonavalent, are currently licensed for use. As part of the National Health Mission, the Government of India launched for the year 2016 for the first time, a population-based prevention, screening, and control program for cervical cancer. The World Health Organization has launched a cervical cancer elimination initiative that looks forward to a cancer-free future. The review concludes that though there are challenges at every level, the solution points in only one direction. All need to work together to ensure the HPV vaccination program is included in our National Immunization Program as the top priority.

Time for Reintroducing HPV Vaccine in Pakistan for Primary Prevention of Cervical Cancer.

Null.

Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial.

In women vaccinated against human papillomavirus (HPV), reductions in cervical disease and related procedures results in more women having intact transformation zones, potentially increasing the risk of cervical lesions caused by non-vaccine-preventable HPV types, a phenomenon termed clinical unmasking. We aimed to evaluate HPV vaccine efficacy against cervical intraepithelial neoplasia grade 2 or worse (CIN2+) and cervical intraepithelial neoplasia grade 3 or worse (CIN3+) attributed to non-preventable HPV types in the long-term follow-up phase of the Costa Rica HPV Vaccine Trial (CVT). CVT was a randomised, double-blind, community-based trial done in Costa Rica. Eligible participants were women aged 18-25 years who were in general good health. Participants were randomly assigned (1:1) to receive an HPV 16 and 18 AS04-adjuvanted vaccine or control hepatitis A vaccine, using a blocked randomisation method (permuted block sizes of 14, 16, and 18). Vaccines in both groups were administered intramuscularly with 0·5 mL doses at 0, 1, and 6 months. Masking of vaccine allocation was maintained throughout the 4-year randomised trial phase, after which participants in the hepatitis A virus vaccine control group were provided the HPV vaccine and exited the study; a screening-only, unvaccinated control group was enrolled. The unvaccinated control group and HPV vaccine group were followed up for 7 years, during which treatment allocation was not masked. One of the prespecified primary endpoints for the long-term follow-up phase was precancers associated with HPV types not prevented by the vaccine, defined as histologically confirmed incident CIN2+ events or CIN3+ events attributed to any HPV type except HPV 16, 18, 31, 33, and 45. Our primary analytical period was years 7-11. Primary analyses were in all participants with at least one follow-up visit and excluded participants with a previous endpoint (ie, modified intention-to-treat cohort). Safety endpoints have been reported elsewhere. This trial is registered with ClinicalTrials.gov, NCT00128661 and NCT00867464. The randomised, masked trial phase is completed; an unmasked subset of women in the HPV-vaccinated group is under active investigation. Between June 28, 2004, and Dec 21, 2005, 7466 participants were enrolled (HPV vaccine group n=3727 and hepatitis A virus vaccine control group n=3739). Between March 30, 2009, and July 5, 2012, 2836 women enrolled in the new unvaccinated control group. The primary analytical cohort (years 7 to 11) included 2767 participants in the HPV vaccine group and 2563 in the unvaccinated group for the CIN2+ events endpoint assessment and 2826 participants in the HPV vaccine group and 2592 in the unvaccinated control group for the CIN3+ events endpoint assessment. Median follow-up during years 7 to 11 for women included for the CIN2+ events analysis was 52·8 months (IQR 44·0 to 60·7) for the HPV vaccine group and 49·8 months (42·0 to 56·9) for the unvaccinated control group. During years 7 to 11, clinical unmasking was observed with a negative vaccine efficacy against CIN2+ events attributed to non-preventable HPV types (-71·2% [95% CI -164·0 to -12·5]), with 9·2 (95% CI 2·1 to 15·6) additional CIN2+ events attributed to non-preventable HPV types per 1000 HPV-vaccinated participants versus HPV-unvaccinated participants. 27·0 (95% CI 14·2 to 39·9) fewer CIN2+ events irrespective of HPV type per 1000 vaccinated participants were observed during 11 years of follow-up. Vaccine efficacy against CIN3+ events attributed to non-preventable HPV types during years 7 to 11 was -135·0% (95% CI -329·8 to -33·5), with 8·3 (3·0 to 12·8) additional CIN3+ events attributed to non-preventable HPV types per 1000 vaccinated participants versus unvaccinated participants. Higher rates of CIN2+ events and CIN3+ events due to non-preventable HPV types in vaccinated versus unvaccinated participants suggests clinical unmasking could attenuate long-term reductions in high-grade disease following successful implementation of HPV vaccination programmes in screened populations. Importantly, the net benefit of vaccination remains considerable; therefore, HPV vaccination should still be prioritised as primary prevention for cervical cancer. National Cancer Institute and National Institutes of Health Office of Research on Women's Health. For the Spanish translation of the abstract see Supplementary Materials section.

Attitude and Family Support Influenced Human Papilloma Virus Vaccination in Female Midwifery Students

Background: In 2019 there were 13,078 cases of cervical cancer in East Java, and in 2018 the prevalence reached 2.2 per 1,000 population. However, the coverage of HPV (Human Papilloma Virus) vaccination as primary prevention of cervical cancer in Indonesia is still low. The purpose of this study was to analyze the influencing factors and the most influencing factors for female midwifery students in Human Papilloma Virus vaccination. Subjects and Method: This was an observational analytic study with a cross sectional design. The study was conducted in East Java. The study population was midwifery students. A sample of 252 midwifery students in East Java was selected by consecutive sampling. The dependent variable was HPV vaccination. The independent variables are attitudes and family support. The data were collected by online questionnaire form and analyzed by a multiple logistic regression. Results: Family support increased the likelihood of HPV vaccination in midwifery students (OR= 5.03; CI = 1.83 to 13.76; p= 0.002). Conclusion: Family support increased the likelihood of HPV vaccination in midwifery students.

Wirus brodawczaka ludzkiego a rak szyjki macicy – znaczenie działań edukacyjnych w ginekologii wieku rozwojowego w kontekście profilaktyki onkologicznej. Rola opieki pielęgniarskiej i lekarskiej

Early prevention of HPV infections is part of the primary prevention of cervical cancer. Vaccines are available to prevent long-term infection with oncogenic HPV serotypes. Also in the aspect of gynecology of developmental age, it is important that the doctor fulfills his tasks in the entire team of other doctors and the medical service, and the nursing staff is of particular importance in this team and in this field. This significance is expressed not only in providing care according to medical recommendations and performing typical nursing activities, but also in taking actions significant in the promotion of health and disease prevention, in pro-health education and in the context of sexual education not only of patients in developmental age, but also of their parents, caregivers. It is hoped that in the future the combination of screening tests and vaccination of anti-oncogenic HPV strains will reduce the incidence of cervical cancer. These activities are related to the holistic care of girls and women, which is always of particular importance, and during the covid 19 pandemic it has a special dimension.

Knowledge, attitudes, and perceptions associated with HPV vaccination among female Korean and Chinese university students

BackgroundHuman papillomavirus (HPV) vaccination is a form of primary prevention for cervical cancer. The HPV vaccination rate of female university students is not high in Korea and China. Therefore, the purpose of this study was to identify and compare the factors associated with intention to receive HPV vaccination between Korean and Chinese female university students.MethodsThe participants were 273 Korean and 317 Chinese female university students who had not been vaccinated for HPV, and data were collected using a self-reported questionnaire about attitudes toward HPV vaccination, HPV knowledge, perceptions of HPV infection, and intention to receive HPV vaccine.ResultsThere were no significant differences between the Korean and Chinese female university students in HPV knowledge, attitudes, perceptions, and vaccination intention. The factors influencing the intention of HPV vaccination in Korean students were a positive attitude toward the HPV vaccine and a high HPV knowledge score. For Chinese students, sexual experience, awareness of genital warts, a positive attitude toward the HPV vaccine, a high HPV knowledge scores, a perception of the seriousness of HPV infection, and negative emotions regarding HPV infection were significant factors.ConclusionsIt is important to improve attitudes and knowledge about HPV and the HPV vaccine in order to enhance HPV vaccination both in Korea and China. Perceived seriousness and negative emotions regarding HPV infection should be used as a framework to develop subject-tailored interventions in China.

Nurses' and teachers' perceived barriers and facilitators to the uptake of the Human Papilloma Virus (HPV)vaccination program in Iquitos, Peru: A qualitative study.

Globally, over 300,000 women die of cervical cancer annually. Given that human papillomavirus vaccines are highly effective in the primary prevention of cervical cancer, it is important to explore the barriers and facilitators to vaccination uptake in areas where the burden of disease remains high. This study, informed by the socio-ecological model, aimed to qualitatively explore vaccination uptake via in-depth interviews with eleven nurses and ten teachers involved in vaccine delivery in Iquitos, Peru. The results highlighted that vaccine uptake was influenced by multiple factors including individuals’ knowledge and attitudes, community beliefs, geography, and policy level variables. Findings suggested that professionals were informed and supportive of the HPV vaccination program but perceived that parents were uninformed about the vaccine. There is a need for community education programs, for a revision of the process of obtaining parental consent, for improved communication between professionals and for involvement of grassroots staff in policy making.

Is Pap Test Awareness Critical to Pap Test Uptake in Women Living in Rural Vietnam?

Introduction:Cervical cancer is the second leading cause of cancer death among Vietnamese females. By detecting precancerous cells, Pap test screening plays a critical role in the fight against cervical cancer. The present study aims to investigate health-related factors associated with receipt of Pap test among Vietnamese females living in rural Vietnam, particularly examining the correlation between awareness level of the Pap test and the receiving of Pap test. Methods:Anderson’s Behavioral Model of Health Services Use was utilized as the present study’s theoretical framework. A self-administrated questionnaire was completed among 193 females residing in Quantri City, Vietnam. Results:Only 15.5% (N=30) of participants in our sample have had a Pap test. Pap test awareness (OR = 18.38, p<.001) was a strong predictor of Pap test receipt. Participants who had heard about Pap test were 18.38 times more likely to take a Pap test compared to those who had no prior knowledge. Besides the awareness, variables including employment (OR = .18, p<.05), and health insurance coverage (OR = 10.75, p<.05) were significantly associated with Pap test uptake. Conclusion:Findings from the present study suggests interventions should be provided through public health efforts to enhance awareness of Pap test by aiming at increasing primary prevention of cervical cancer, especially among Vietnamese women living in rural areas, in order to reduce cancer health disparities.

HPV Vaccination in Bangladesh: Ethical Views.

Human papillomavirus (HPV) vaccination of young adolescent girls as a part of primary prevention of cervical cancer is now a routine practice in many countries. Bangladesh, a lower-middle income country, observed a successful HPV vaccination demonstration program recently. As much as the benefits of the vaccination programs are well-recorded, the ethics of administration of it is not focused highly; rather the focus tends to be on the most efficient method to get it done. In countries like Bangladesh, vaccination-related ethical issues are often overlooked. Thus, addition of HPV vaccination to the existing immunization programs calls for logical discussion and consideration to preserve the highest ethical standard in administering this vaccine to a sensitive age group of adolescence. This chapter summarizes some ethical concerns related to the HPV vaccination implementation in Bangladesh.

A study on the Impact of Cancer Awareness Program in improving the awareness and vaccine uptake for Cervical cancer in Nursing students of a tertiary care hospital of Bhubaneswar

Despite the evidence of Human Papilloma Virus vaccination, as an effective mode of primary prevention of cervical cancer, the uptake of vaccine is very less. There being a lot of gaps regarding knowledge about HPV vaccination, its safety, efficacy and availability, the study was done to assess the effect of awareness programs in the acceptance of safe practices for prevention of cervical cancer. Using a longitudinal study design, a study was conducted among 152 B.Sc. nursing students of a tertiary care teaching hospital; using a researcher-made questionnaire. An awareness session was organized to educate them on cervical cancer prevention. The same questionnaire was re-administered as a post- test after a period of one month. Data collected was entered into Microsoft excel spreadsheet; analyzed using EpiInfo software. Data was represented using appropriate statistical tests; taking a p-value of &lt; 0.05 as statistically significant. The mean-age of the study participants was 20.92 + 1.68 years. As few as15.1% knew that “HPV infection is generally asymptomatic”, pre-awareness session. There was considerable improvement in the knowledge regarding the symptoms of carcinoma of cervix post the awareness drive, results were was also statistically significant (p&lt; 0.001). Similarly, their knowledge regarding various risk factors of carcinoma cervix, PAP smear test as a screening tool, also had a marked improvement, post the awareness session. 52.6% were hesitant to take the HPV vaccine pre-awareness session, whereas 73.6% agreed for the same after the awareness program. Although prior to the awareness drive their knowledge about cervical cancer was poor, but there was a significant improvement in their level of knowledge after it. Thus awareness programs can be conducted to inculcate safe lifestyle practices. For wider dissemination, more numbers of awareness drives and at frequent intervals should be done.

The Effectiveness of Education to Increase Motivation and Primary Cervical Cancer Prevention Actions

Cervical cancer is a type of malignancy found among women, with the second highest number of sufferers globally aged 15 to 44. However, the motivation for women to do cervical cancer prevention is still low. This study aimed to test the effectiveness of education on motivation and primary prevention measures for cervical cancer in young women. The research method used was an experimental design with a pre-test post-test control group design. The sampling technique used was a proportional random sampling of 150 respondents who met the inclusion criteria, 75 as the experimental group, and 75 as the control group. The statistical test used was Wilcoxon and Mann Whitney test. The Wilcoxon test results showed that the p score was 0.000 &lt;0.05, which means a significant difference in motivation and action in the experimental and control groups before and after education. Test results. Mann Whitney showed a p score was 0.000 &lt;0.05. Based on these results, it can be concluded that education effectively increases motivation and the primary prevention of cervical cancer.